Sfoglia per Autore
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy
2014-01-01 Ylenia Ingrasciotta;Janet Sultana;Francesco Giorgianni;Achille Patrizio Caputi;Vincenzo Arcoraci;Daniele Ugo Tari;Claudio Linguiti;Margherita Perrotta;Andrea Nucita;Fabio Pellegrini;Andrea Fontana;Lorenzo Cavagna;Domenico Santoro;Gianluca Trifirò
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease
2014-01-01 Gianluca Trifirò;Janet Sultana;Francesco Giorgianni;Ylenia Ingrasciotta;Michele Buemi;Marco Muscianisi;Daniele Ugo Tari;Margherita Perrotta;Valeria Canale;Vincenzo Arcoraci;Domenico Santoro
Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013
2015-01-01 Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ien6le, Valen6na; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebas6ano Pollina; Scondo_o, Salvatore; Cananzi, Pasquale; Caputi Achille, Patrizio; Trifiro', Gianluca
The advent of biosimilars for the treatment of diabetes: current status and future directions
2015-01-01 Polimeni, G.; Trifiro, G.; Ingrasciotta, Y.; Caputi, A. P.
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study
2015-01-01 Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Fontana, Andrea; Santangelo, Antonio; Tari, Daniele Ugo; Santoro, Domenico; Arcoraci, Vincenzo; Perrotta, Margherita; Ibanez, Luisa; Trifiro', Gianluca
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013
2015-01-01 Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ientile, Valentina; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebastiano Pollina; Scondotto, Salvatore; Cananzi, Pasquale; Caputi, Achille Patrizio; Trifirò, Gianluca
Medication is an additional source of phosphate intake in chronic kidney disease patients
2015-01-01 Sultana, J.; Musazzi, U.M.; Ingrasciotta, Y.; Giorgianni, F.; Ientile, V.; Fontana, A.; Minghetti, P.; Perrotta, M.; Santoro, D.; Savica, V.; Trifirò, G
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study
2016-01-01 Ingrasciotta, Ylenia; Giorgianni, Francesco; Marcianò, Ilaria; Bolcato, Jenny; Pirolo, Roberta; Chinellato, Alessandro; Ientile, Valentina; Santoro, Domenico; Genazzani, Armando A.; Alibrandi, Angela; Fontana, Andrea; Caputi, Achille; Trifiro', Gianluca
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study
2016-01-01 E., Viola; Trifirò, G.; Ingrasciotta, Ylenia; Sottosanti, Laura; M., Tari; Giorgianni, Francesco; U., Moretti; R., Leone
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014
2016-01-01 Marcianò, Ilaria; Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Di Giorgio, Annalisa; Manna, Sonia; Ientile, Valentina; Gini, Rosa; Santarpia, Mariacarmela; Genazzani, Armando A.; Uomo, Ilaria; Pastorello, Maurizio; Pollina Addario, Sebastiano W.; Scondotto, Salvatore; Cananzi, Pasquale; Da Cas, Roberto; Traversa, Giuseppe; Rossi, Mariangela; Sottosanti, Laura; Caputi, Achille P.; Trifirò, Gianluca
Biosimilars in Italy: What do real-world data reveal?
2017-01-01 Trifiro, G.; Ingrasciotta, Y.; Marciano, I.; Genazzani, A.
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence.
2017-01-01 Trifiro', Gianluca; Marciano', Ilaria; Ingrasciotta, Ylenia
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
2018-01-01 Trifirò, G; Gini, R; Barone-Adesi, F; Beghi, E; Cantarutti, A; Capuano, ANNAMARIA AGATA ITALIA; Carnovale, C; Clavenna, A; Dellagiovanna, M; Ferrajolo, C; Franchi, M; Ingrasciotta, Y; Kirchmayer, U; Lapi, F; Leone, R; Leoni, O; Lucenteforte, E; Moretti, U; Mugelli, A; Naldi, L; Poluzzi, E; Rafaniello, C; Rea, F; Sultana, J; Tettamanti, M; Traversa, G; Vannacci, A; Mantovani, L; Corrao, G
The economic burden of preventable adverse drug reactions: a systematic review of observational studies
2018-01-01 Formica, D; Sultana, J; Cutroneo, Pm; Lucchesi, S; Angelica, R; Crisafulli, S; Ingrasciotta, Y; Salvo, F; Spina, E; Trifirò, G
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction.
2018-01-01 Ingrasciotta, Y; Cutroneo, Pm; Marcianò, I; Giezen, T; Atzeni, F; Trifirò, G.
Pharmacokinetics of new oral anticoagulants: implications for use in routine care
2018-01-01 Ingrasciotta, Ylenia; Crisafulli, Salvatore; Pizzimenti, Valeria; Marciano', Ilaria; Mancuso, Anna; Ando', Giuseppe; Corrao, Salvatore; Capranzano, Piera; Trifiro', Gianluca
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014
2018-01-01 Marcianò, I; Ingrasciotta, Y; Giorgianni, F; Ientile, V; Chinellato, A; Tari, Du; Gini, R; Cannavò, S; Pastorello, M; Scondotto, S; Cananzi, P; Traversa, G; Trotta, F; Belleudi, V; Addis, A; Trifirò, G
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari
2019-01-01 Ingrasciotta, Ylenia; Trifiro', Gianluca
1. Real World Evidence vs. Real World Data: definizioni e razionale
2019-01-01 Trifiro', Gianluca; Ingrasciotta, Ylenia
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy
2019-01-01 Ingrasciotta, Y.; Sultana, J.; Kirchmayer, U.; Trifiro, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy | 1-gen-2014 | Ylenia Ingrasciotta;Janet Sultana;Francesco Giorgianni;Achille Patrizio Caputi;Vincenzo Arcoraci;Daniele Ugo Tari;Claudio Linguiti;Margherita Perrotta;Andrea Nucita;Fabio Pellegrini;Andrea Fontana;Lorenzo Cavagna;Domenico Santoro;Gianluca Trifirò | |
| Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease | 1-gen-2014 | Gianluca Trifirò;Janet Sultana;Francesco Giorgianni;Ylenia Ingrasciotta;Michele Buemi;Marco Muscianisi;Daniele Ugo Tari;Margherita Perrotta;Valeria Canale;Vincenzo Arcoraci;Domenico Santoro | |
| Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013 | 1-gen-2015 | Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ien6le, Valen6na; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebas6ano Pollina; Scondo_o, Salvatore; Cananzi, Pasquale; Caputi Achille, Patrizio; Trifiro', Gianluca | |
| The advent of biosimilars for the treatment of diabetes: current status and future directions | 1-gen-2015 | Polimeni, G.; Trifiro, G.; Ingrasciotta, Y.; Caputi, A. P. | |
| Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study | 1-gen-2015 | Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Fontana, Andrea; Santangelo, Antonio; Tari, Daniele Ugo; Santoro, Domenico; Arcoraci, Vincenzo; Perrotta, Margherita; Ibanez, Luisa; Trifiro', Gianluca | |
| How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013 | 1-gen-2015 | Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ientile, Valentina; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebastiano Pollina; Scondotto, Salvatore; Cananzi, Pasquale; Caputi, Achille Patrizio; Trifirò, Gianluca | |
| Medication is an additional source of phosphate intake in chronic kidney disease patients | 1-gen-2015 | Sultana, J.; Musazzi, U.M.; Ingrasciotta, Y.; Giorgianni, F.; Ientile, V.; Fontana, A.; Minghetti, P.; Perrotta, M.; Santoro, D.; Savica, V.; Trifirò, G | |
| Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study | 1-gen-2016 | Ingrasciotta, Ylenia; Giorgianni, Francesco; Marcianò, Ilaria; Bolcato, Jenny; Pirolo, Roberta; Chinellato, Alessandro; Ientile, Valentina; Santoro, Domenico; Genazzani, Armando A.; Alibrandi, Angela; Fontana, Andrea; Caputi, Achille; Trifiro', Gianluca | |
| Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study | 1-gen-2016 | E., Viola; Trifirò, G.; Ingrasciotta, Ylenia; Sottosanti, Laura; M., Tari; Giorgianni, Francesco; U., Moretti; R., Leone | |
| How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014 | 1-gen-2016 | Marcianò, Ilaria; Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Di Giorgio, Annalisa; Manna, Sonia; Ientile, Valentina; Gini, Rosa; Santarpia, Mariacarmela; Genazzani, Armando A.; Uomo, Ilaria; Pastorello, Maurizio; Pollina Addario, Sebastiano W.; Scondotto, Salvatore; Cananzi, Pasquale; Da Cas, Roberto; Traversa, Giuseppe; Rossi, Mariangela; Sottosanti, Laura; Caputi, Achille P.; Trifirò, Gianluca | |
| Biosimilars in Italy: What do real-world data reveal? | 1-gen-2017 | Trifiro, G.; Ingrasciotta, Y.; Marciano, I.; Genazzani, A. | |
| Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence. | 1-gen-2017 | Trifiro', Gianluca; Marciano', Ilaria; Ingrasciotta, Ylenia | |
| The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? | 1-gen-2018 | Trifirò, G; Gini, R; Barone-Adesi, F; Beghi, E; Cantarutti, A; Capuano, ANNAMARIA AGATA ITALIA; Carnovale, C; Clavenna, A; Dellagiovanna, M; Ferrajolo, C; Franchi, M; Ingrasciotta, Y; Kirchmayer, U; Lapi, F; Leone, R; Leoni, O; Lucenteforte, E; Moretti, U; Mugelli, A; Naldi, L; Poluzzi, E; Rafaniello, C; Rea, F; Sultana, J; Tettamanti, M; Traversa, G; Vannacci, A; Mantovani, L; Corrao, G | |
| The economic burden of preventable adverse drug reactions: a systematic review of observational studies | 1-gen-2018 | Formica, D; Sultana, J; Cutroneo, Pm; Lucchesi, S; Angelica, R; Crisafulli, S; Ingrasciotta, Y; Salvo, F; Spina, E; Trifirò, G | |
| Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction. | 1-gen-2018 | Ingrasciotta, Y; Cutroneo, Pm; Marcianò, I; Giezen, T; Atzeni, F; Trifirò, G. | |
| Pharmacokinetics of new oral anticoagulants: implications for use in routine care | 1-gen-2018 | Ingrasciotta, Ylenia; Crisafulli, Salvatore; Pizzimenti, Valeria; Marciano', Ilaria; Mancuso, Anna; Ando', Giuseppe; Corrao, Salvatore; Capranzano, Piera; Trifiro', Gianluca | |
| Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 | 1-gen-2018 | Marcianò, I; Ingrasciotta, Y; Giorgianni, F; Ientile, V; Chinellato, A; Tari, Du; Gini, R; Cannavò, S; Pastorello, M; Scondotto, S; Cananzi, P; Traversa, G; Trotta, F; Belleudi, V; Addis, A; Trifirò, G | |
| 12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari | 1-gen-2019 | Ingrasciotta, Ylenia; Trifiro', Gianluca | |
| 1. Real World Evidence vs. Real World Data: definizioni e razionale | 1-gen-2019 | Trifiro', Gianluca; Ingrasciotta, Ylenia | |
| Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy | 1-gen-2019 | Ingrasciotta, Y.; Sultana, J.; Kirchmayer, U.; Trifiro, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile